ECMO Nursing Guide — GCC

Extracorporeal Membrane Oxygenation | Critical Care Nursing Reference | Gulf Cooperation Council

● ECMO Types & Configurations

VV-ECMO — Veno-Venous

Respiratory SupportCardiac Function Preserved
  • Blood drained from venous system, oxygenated, returned to venous system
  • Provides gas exchange — no haemodynamic support
  • Requires adequate native cardiac output
  • Typical cannulation: right femoral vein (drainage) → right internal jugular vein (return)
  • Bicaval dual-lumen cannula (Avalon): single-site, right IJV
  • Flow target: 4–6 L/min
Key concept: recirculation — oxygenated blood returns and is immediately drained back → reduces efficiency

VA-ECMO — Veno-Arterial

Cardiac + RespiratoryHaemodynamic Support
  • Blood drained from venous system, returned to arterial system
  • Provides both cardiac output replacement and gas exchange
  • Peripheral: femoral vein → femoral artery (most common)
  • Central: right atrium → ascending aorta (post-cardiac surgery)
  • Initial flow: 3–5 L/min (titrate to haemodynamics)
  • Requires distal perfusion cannula for femoral approach
Afterload increase from retrograde aortic flow — monitor for LV distension

Hybrid Configurations

VAV-ECMO

  • Return to both venous and arterial systems
  • Addresses both respiratory failure and cardiogenic shock
  • Used when VV insufficient due to cardiac dysfunction

VVA-ECMO

  • Two venous drainage sites, one arterial return
  • Increases drainage capacity
  • Used in large patients or poor drainage with single cannula

ECMO Indications

VV-ECMO Indications

  • Refractory ARDS — P/F ratio <80 on optimal MV
  • Severe hypercapnia unresponsive to ventilator changes
  • Air leak syndrome
  • Bridge to lung transplant
  • COVID-19 ARDS (significant GCC experience)

VA-ECMO Indications

  • Cardiogenic shock refractory to vasopressors
  • Cardiac arrest — eCPR (ECMO-CPR)
  • Post-cardiotomy failure (failure to wean from bypass)
  • Bridge to LVAD or cardiac transplant
  • Myocarditis, massive PE

● Key Circuit Components

ComponentFunctionKey Monitoring Points
CannulaeDrainage (venous) and return (venous or arterial) accessPosition, security, exit site integrity, flow adequacy
Centrifugal PumpGenerates blood flow — maglev or hydrodynamic impellerRPM, flow L/min, suction alarms (inadequate drainage)
Oxygenator (Membrane)Gas exchange — O₂ addition, CO₂ removal across hollow fibre membranePre/post membrane pO₂, membrane colour, transmembrane pressure
Heat ExchangerMaintains blood temperature — prevents hypothermiaWater circuit temperature, water level, leaks
TubingConnects all components — PMMA/PVCKinks, clots, air, connection security
Sweep GasGas flowing through oxygenator — controls CO₂ removal (flow rate) and O₂ (FiO₂)Sweep gas flow rate L/min, FiO₂ setting, gas on/off
Pressure MonitorsPre/post pump, pre/post oxygenator pressuresTransmembrane pressure gradient — rising = oxygenator clot

● Circuit Priming

Priming Process

  • Circuit primed with crystalloid (normal saline or Hartmann's) to remove all air
  • Albumin coating of circuit surfaces — reduces thrombogenicity
  • Blood prime in neonates and small children
  • Verify: no visible air bubbles in any part of circuit
  • Check all connections — hand-tight plus quarter-turn
  • Document prime volume — included in fluid balance

Pre-Cannulation Checklist

  • ECMO specialist and perfusionist present
  • Circuit primed and confirmed air-free
  • Emergency hand-crank available at bedside
  • Anticoagulation (UFH bolus) given before cannulation
  • ACT confirmed therapeutic before circuit connection
  • Blood products available (PRBC, FFP, platelets, cryo)
  • Emergency equipment at bedside

● Flow Rates & Targets Summary

VV-ECMO Flow

4–6 L/min

  • Target: SpO₂ 88–95%
  • Adjust sweep gas for CO₂
  • Increase flow for hypoxia

VA-ECMO Flow

3–5 L/min

  • Target: MAP 65–80 mmHg
  • SvO₂ on drainage >65%
  • Cardiac index >2.2 L/min/m²

Sweep Gas

Titrate to ABG

  • FiO₂: 1.0 initially → wean
  • Flow rate → controls PaCO₂
  • Higher sweep = lower PaCO₂

● VV-ECMO Circuit Assessment (Continuous)

ParameterTarget / NormalAction if Abnormal
Pump Speed (RPM)2000–3500 RPM (device specific)If RPM high but flow low → assess for suction/hypovolaemia
Flow (L/min)4–6 L/minIf low: check volume, cannula position, increase RPM cautiously
Sweep Gas FiO₂Titrate — start 1.0, weanIncrease FiO₂ for hypoxia; assess oxygenator function
Sweep Gas Flow RateTitrate to PaCO₂Increase flow to reduce PaCO₂; decrease to raise PaCO₂
Pre-membrane pO₂~40–60 mmHg (venous)Markedly low → high O₂ consumption, adjust support level
Post-membrane pO₂>400 mmHg on FiO₂ 1.0Drop >25% from baseline = oxygenator failure → prepare circuit change
Transmembrane Pressure<50 mmHg gradientRising TMP = oxygenator clot → notify ECMO specialist
Circuit ColourPost-membrane: bright red; Pre: darkPost-membrane dark = oxygenator failure

● Recirculation

Recirculation occurs when oxygenated blood returned to the venous system is immediately re-drained into the circuit before reaching the patient — reducing effective support.

Recognition

  • Both drainage and return limbs appear similarly bright (oxygenated)
  • Patient SpO₂ low despite high ECMO flow and good oxygenator function
  • SaO₂ on drainage sample unexpectedly high (>75%)
  • Recirculation fraction = (SrO₂ − SvO₂) / (SpO₂ − SvO₂)

Management

  • Reposition cannulae — increase distance between tips
  • Reduce ECMO flow temporarily
  • Ensure adequate intravascular volume
  • Consider position change (e.g., Trendelenburg)
  • Imaging to confirm cannula positions (CXR, echo)

● Anticoagulation Management — VV-ECMO

UFH Protocol

  • Unfractionated heparin (UFH) — continuous infusion
  • aPTT target: 55–70 seconds
  • Anti-Xa target: 0.3–0.5 units/mL
  • ACT target: 180–200 seconds
  • Monitor ACT every 4–6 hours
  • aPTT or anti-Xa: 6-hourly until stable, then 12-hourly
Lower anticoagulation targets acceptable if active bleeding — discuss with ECMO team and haematology

HIT Surveillance & Management

  • Monitor platelet count daily
  • HIT suspect: platelet drop >50% from baseline, 5–10 days post-heparin
  • Send HIT antibody (anti-PF4/heparin) ELISA
  • If HIT suspected: stop all heparin immediately
  • Switch to direct thrombin inhibitor: Argatroban
  • Argatroban target: aPTT 45–80 seconds (institution specific)
  • Bivalirudin: alternative — monitor aPTT or ECT
HIT on ECMO is life-threatening — rapid circuit thrombosis risk. Escalate immediately.

● SpO₂ Targets & Native Lung Ventilation

Oxygenation Targets — VV-ECMO

SpO₂ 88–95% is acceptable on VV-ECMO. Do not over-treat mild hypoxia — permissive hypoxaemia reduces lung injury.
  • PaO₂ 55–80 mmHg acceptable
  • Haemoglobin target: 10–12 g/dL (transfuse PRBC if below)
  • Optimise ECMO flow before escalating ventilator settings

Lung Rest Ventilation Strategy

Goal: minimise ventilator-induced lung injury while ECMO supports gas exchange.
ParameterLung Rest Target
Tidal Volume3–4 mL/kg IBW
Respiratory Rate10–15 breaths/min
PEEP10–15 cmH₂O
FiO₂ (vent)0.3–0.5
Plateau Pressure<25 cmH₂O

● Haemodynamic Targets — VA-ECMO

ParameterTargetClinical Note
MAP65–80 mmHgHigher MAP may increase LV afterload — balance carefully
Heart Rate60–100 bpmTachycardia increases myocardial O₂ demand
CVP8–12 mmHgVery high CVP → consider RV failure or fluid overload
SvO₂ (drainage line)>65%Low SvO₂ = inadequate O₂ delivery → increase flow or Hb
LactateTrend downward, target <2 mmol/LRising lactate = inadequate perfusion or ischaemia
Urine output>0.5 mL/kg/hrOliguria = inadequate flow or AKI — consider RRT
ECMO Flow3–5 L/minTitrate to above targets; avoid excessive flow causing LV distension

● Arterial Line Monitoring — Harlequin Syndrome

Harlequin / North-South Syndrome: In femoral VA-ECMO — well-oxygenated ECMO blood (from femoral artery) competes with poorly oxygenated blood from native heart ejection. Upper body (brain, right arm) may receive hypoxic blood while lower body is well-oxygenated.

Dual Arterial Line Strategy

  • Peripheral line: radial artery (right side preferred) — monitors native cardiac output oxygenation
  • Central line: femoral or aortic — monitors ECMO circuit perfusion
  • Compare SpO₂ from right hand vs lower limb
  • If right hand SpO₂ < lower limb SpO₂ = Harlequin

Harlequin Management

  • Optimise native lung ventilation (increase FiO₂, PEEP)
  • Add venous drainage to jugular (VAV configuration)
  • Increase ECMO flow to maximise retrograde oxygenated blood reaching arch
  • Consider transition to central cannulation
  • Monitor cerebral oximetry (NIRS) if available

● Cardiac Recovery Monitoring

Signs of Native Heart Recovery

  • Improving pulsatility on arterial waveform — pulse pressure widening
  • Aortic valve opening on echocardiogram
  • Improving LVEF on serial echo
  • Ability to reduce ECMO flow without haemodynamic deterioration
  • Decreasing vasopressor requirements
  • Improving lactate and SvO₂

Echocardiographic Assessment

  • Daily TTE or TOE assessment on VA-ECMO
  • LVEF measurement — target improvement to >20–25% before weaning trial
  • Assess aortic valve opening — if not opening, LV distension risk
  • LV end-diastolic diameter — increasing = distension
  • Mitral regurgitation severity
  • RV function assessment
ECMO weaning trial: stepwise reduction of flow under echo guidance with haemodynamic monitoring

● LV Distension — Recognition & Venting

VA-ECMO increases LV afterload (retrograde aortic flow). If native heart cannot eject adequately, LV distends → pulmonary oedema → lung haemorrhage. Requires urgent intervention.

Recognition

  • Pulmonary oedema on CXR
  • Increased PCWP / LAP
  • Aortic valve not opening
  • LV dilation on echo
  • Falling SpO₂

LV Venting Options

  • Impella — transaortic LV unloading device (preferred)
  • IABP — intra-aortic balloon pump
  • Atrial septostomy — blade/balloon septostomy
  • Surgical LV vent (central ECMO)

Nursing Actions

  • Escalate to ECMO specialist immediately
  • Prepare for bedside echo
  • Have diuretics ready (if residual renal function)
  • Document CXR findings and trends
  • Monitor SpO₂ continuously

● Lower Limb Ischaemia — Distal Perfusion Cannula

Femoral arterial return cannula may obstruct distal perfusion to the leg — limb ischaemia risk. Distal perfusion cannula (DPC) inserted into superficial femoral artery is standard of care.

Hourly Limb Assessment — VA-ECMO

  • Distal pulses: dorsalis pedis, posterior tibial — Doppler if not palpable
  • Capillary refill time: <2 seconds normal
  • Temperature: compare both limbs — cool = ischaemia
  • Colour: pallor, mottling, cyanosis
  • SpO₂ probe on great toe of cannulated limb
  • Pain/paraesthesia in awake patients
  • Document findings hourly — escalate immediately if deteriorating

DPC Management

  • Confirm DPC flow — visible pulsatile blood flow
  • DPC connected to ECMO circuit return limb via Y-connector
  • Keep DPC site clean and patent
  • Compartment syndrome: hard, tense calf → escalate urgently
  • Rhabdomyolysis: CK, myoglobinuria monitoring
Any new signs of limb ischaemia = immediate ECMO specialist notification. Irreversible damage within hours.

● Circuit Emergencies

Oxygenator Failure

Emergency

Recognition

  • Dark venous-coloured blood at post-membrane sampling port
  • Post-membrane pO₂ drop >25% from baseline
  • Patient SpO₂ falling despite adequate ECMO flow
  • Rising transmembrane pressure gradient
  • Visible plasma leak from oxygenator (white/pink fluid)

Actions

  • Notify ECMO specialist immediately
  • Increase ventilator support temporarily
  • Prepare emergency oxygenator/circuit change
  • Have blood products available

Circuit Clot / Thrombosis

Emergency

Recognition

  • Visible dark fibrin strands on visual inspection
  • Circuit "chatter" — vibration/shaking = clot causing turbulence
  • Unexplained drop in ECMO flow at same RPM
  • Rising pump pressures
  • Haemolysis (rising plasma-free Hb, haemoglobinuria)

Actions

  • Increase anticoagulation if sub-therapeutic
  • Inspect full circuit systematically
  • Prepare circuit change — assemble ECMO team
  • Do NOT clamp circuit without specialist instruction

Air Embolism

Life-Threatening Emergency

Recognition

  • Visible air bubbles in circuit tubing
  • Frothy appearance of blood in circuit
  • Sudden drop in ECMO flow
  • Patient haemodynamic deterioration

Immediate Actions

  • STOP pump immediately
  • Clamp all lines
  • Call ECMO specialist STAT
  • Trendelenburg position
  • Never restart until air completely cleared

Haemolysis

Urgent

Recognition

  • Plasma-free haemoglobin >500 mg/L
  • Pink/red discolouration of plasma or urine
  • Falling haematocrit
  • Rising LDH, indirect bilirubin

Actions

  • Check for tubing kinks, tight connections
  • Reduce RPM if clinically safe
  • Ensure adequate anticoagulation
  • Increase urine output (protect kidneys)
  • Circuit change if persistent (>500 mg/L)

● Patient Complications

Bleeding — Most Common Complication

ECMO requires continuous anticoagulation + circuit-induced platelet dysfunction and fibrinogen consumption → high bleeding risk.

Sites

  • Cannula sites (most common)
  • Surgical sites
  • GI tract (stress ulceration)
  • Intracranial (most feared)
  • Pulmonary haemorrhage

Management

  • Reduce UFH infusion (accept lower ACT/aPTT)
  • Transfuse PRBC (Hb target 10–12 g/dL)
  • Platelet transfusion if <50–80 × 10⁹/L
  • FFP for coagulopathy (PT/APTT >1.5×)
  • Cryoprecipitate if fibrinogen <1.5 g/L
  • Tranexamic acid (selected cases)
  • Surgical haemostasis at cannula sites

Neurological Injury

Neurological complications: stroke (ischaemic and haemorrhagic), seizures, hypoxic-ischaemic injury — carry high mortality on ECMO.

Monitoring

  • Daily neurological examination (when sedation allows)
  • GCS assessment every 4 hours minimum
  • Pupil assessment with each neurological check
  • TCD (transcranial Doppler) — cerebrovascular flow monitoring
  • NIRS/cerebral oximetry continuous monitoring
  • CT head if any neurological change

Prevention

  • Maintain MAP 65–80 mmHg consistently
  • Avoid hyperthermia (normothermia)
  • Optimise anticoagulation — prevent both clot and bleed
  • Light sedation when possible — enables neurological assessment

Cannula Complications

During cannulation

  • Vessel injury, arteriovenous fistula, haematoma
  • Pneumothorax (jugular cannulation)
  • Cardiac perforation (right heart)

During ECMO run

  • Cannula dislodgement — life-threatening haemorrhage
  • Cannula malposition — reduced flow
  • Exit site infection

At decannulation

  • Haematoma formation
  • Vascular injury requiring surgical repair
  • Pseudoaneurysm

Renal Failure & Other Organ Complications

AKI

  • Common — multifactorial (haemolysis, haemodynamic instability, nephrotoxins)
  • Monitor urine output hourly
  • Renal replacement therapy frequently required on ECMO
  • CRRT can be connected to ECMO circuit (post-pump, pre-oxygenator)

Infection / Sepsis

  • ECMO circuit is foreign body — infection risk
  • VAP prevention protocols essential
  • Line care bundles for all vascular access
  • Regular surveillance cultures

● Patient Positioning & Mobility

Positioning Guidelines

  • HOB 30°: standard position — reduces VAP risk, improves respiratory mechanics
  • Central cannula patients: minimal repositioning — log roll ONLY with ECMO specialist present
  • Peripheral cannula (femoral): restrict hip flexion on cannulated limb (<30°)
  • Prone positioning on VV-ECMO: possible in specialist centres — requires full team

Mobility — VV-ECMO Walking Protocol

Awake, mobilised VV-ECMO patients (bridge to transplant) have improved outcomes. Selected centres in GCC implementing walking ECMO.
  • Eligibility: awake, cooperative, haemodynamically stable, peripheral cannulae
  • Minimum team: ECMO specialist + 2 nurses + physiotherapist
  • Ensure circuit length adequate for ambulation
  • SpO₂, HR, MAP continuous monitoring during mobility
  • Progressive: dangling → standing → walking

● Nutrition & Metabolic Care

Nutritional Support

  • Early enteral nutrition: start within 24–48h of ECMO initiation
  • Route: NGT preferred; post-pyloric if gastric intolerance
  • ECMO increases metabolic rate — indirect calorimetry if available
  • Target: 25–30 kcal/kg/day protein 1.5–2g/kg/day
  • Monitor gastric residuals (GRV) — ECMO may reduce GI motility
  • Prokinetics (metoclopramide, erythromycin) if high GRV
  • Parenteral nutrition if EN not achievable by day 3–5

Metabolic Monitoring

  • Blood glucose 6–10 mmol/L — insulin infusion as needed
  • Electrolytes: Na, K, Mg, Phosphate, Ca — correct daily
  • Drug dosing altered on ECMO — circuit absorbs lipophilic drugs
  • Sedatives (midazolam, fentanyl): significantly absorbed — higher doses needed
  • Antibiotics: some require dose adjustment (check pharmacy)
  • Temperature management: normothermia via heat exchanger

● Pressure Care & Skin Integrity

● Cannula Site Care

Routine Cannula Care

  • Aseptic non-touch technique for all dressing changes
  • Dressing change: 48-hourly (or sooner if soiled/loose)
  • Transparent dressing preferred — visible exit site inspection
  • Exit site inspection: daily — redness, discharge, haematoma, movement
  • Cannula secured with sutures + additional fixing — document
  • Never remove or reposition cannulae without ECMO specialist
  • Mark cannula depth/position at commencement — reassess each shift

Infection Prevention

  • Full barrier precautions for cannula access
  • CHG (chlorhexidine gluconate) dressings at exit sites
  • CHG bathing: daily whole-body wash
  • Exit site swabs if infection suspected
  • Blood cultures (peripheral + central) if fever or unexplained deterioration
  • Remove unnecessary venous catheters — minimise infection sources

● Psychological Care & Communication

Awake ECMO Patients

Awake VV-ECMO patients (bridge to transplant, weaning trials) face profound psychological challenges.
  • ECMO machine noise — constant anxiety trigger
  • Immobility (circuit limitations)
  • Fear of circuit disconnection or emergency
  • ICU delirium — assess with CAM-ICU daily
  • If intubated — cannot verbalise fears
  • Communication aids: letter boards, tablets, eye gaze devices
  • Regular psychological assessment
  • Sleep hygiene: noise reduction, light management, sedation minimisation

Family Support

  • Pre-visit preparation: ECMO is alarming — explain circuit, alarms, appearance before first visit
  • Show family photos of the circuit and equipment in advance
  • Assign family liaison nurse — consistent communication
  • Daily family meetings with ECMO/ICU team
  • Involve family in care (hand-holding, speaking to patient)
  • Spiritual support: hospital chaplain, Imam access in GCC ICUs
  • Allow Arabic Quranic recitation — contributes to patient comfort

● Oral Care & VAP Prevention

● ECMO Centres in the GCC

CentreCountryECMO Programme Highlights
King Faisal Specialist Hospital & Research CentreSaudi Arabia (Riyadh)Major adult and paediatric ECMO programme; significant cardiac and respiratory ECMO volume; ECMO for post-cardiac surgery; active research programme
Cleveland Clinic Abu DhabiUAE (Abu Dhabi)Advanced cardiac surgery programme; VA and VV ECMO; ECMO for cardiac transplant bridge; trained specialist nursing team
Hamad Medical Corporation (HMC)Qatar (Doha)National ECMO programme; gained significant experience during COVID-19; ECMO transport capability; paediatric ECMO
King Abdullah Medical City (KAMC)Saudi Arabia (Makkah)ECMO during Hajj season — unique context of mass gathering medicine
King Fahad Medical CitySaudi Arabia (Riyadh)Paediatric ECMO focus; congenital heart disease post-repair support
Oman and Kuwait tertiary centresOman, KuwaitDeveloping ECMO programmes; referral to Saudi Arabia/UAE for complex cases

● ECMO & Infectious Disease Experience — GCC

MERS-CoV ECMO Experience

  • Middle East Respiratory Syndrome Coronavirus — endemic in Arabian Peninsula
  • Severe MERS-CoV ARDS: P/F ratio <80 — VV-ECMO indication
  • Saudi Arabia accumulated significant VV-ECMO experience for MERS
  • Outcomes data published from KFSHRC and other Saudi centres
  • Infection control: ECMO for MERS required full PPE — N95, gown, gloves, eye protection
  • Circuit management with aerosolisation precautions

COVID-19 ECMO Experience

  • GCC hospitals established/expanded ECMO programmes during COVID-19 pandemic (2020–2022)
  • Qatar (HMC) and UAE treated international patients on ECMO
  • ELSO COVID-19 guidelines followed across GCC
  • VV-ECMO for COVID-ARDS: P/F <80 despite optimal proning and ventilation
  • Extended ECMO runs (weeks to months) — unique nursing challenges
  • Nursing staff rapidly trained and upskilled during pandemic

● ECMO Transport in GCC

Inter-hospital ECMO transport (mobile ECMO) allows patients to be cannulated at referring hospital and transported on ECMO to specialist centre — expanding access across GCC.

Mobile ECMO Team Composition

  • ECMO specialist physician (intensivist/cardiac surgeon)
  • ECMO specialist nurse
  • Perfusionist or ECMO technician
  • Additional transport nurse/paramedic
  • Transport: ground ambulance (short distance), helicopter or fixed-wing aircraft (inter-emirate/cross-border)

Transport Nursing Considerations

  • Transport ECMO console — battery-powered, certified for air transport
  • Adequate drug and blood product supply for transport duration
  • Secure all connections before movement
  • Ventilator transport settings — anticipate vibration effects
  • Communication with receiving team pre-arrival
  • Documentation: ECMO parameters logged throughout transport

● ECMO Nurse Specialist Training — GCC Standards

ELSO Guidelines — GCC Adoption

  • Extracorporeal Life Support Organisation (ELSO) — international standards body
  • GCC centres following ELSO guidelines for circuit management, anticoagulation, weaning
  • ELSO registry participation — data submission from major GCC centres
  • ELSO training courses offered at GCC centres

Nurse Specialist Training Pathway

  • ICU registered nurse with ≥2 years critical care experience
  • ECMO theory training: circuit physics, pathophysiology, pharmacology
  • Simulator training: circuit management, emergency scenarios
  • Supervised clinical practice: minimum case numbers
  • Competency assessment: annual recertification
  • ECMO Coordinator role in major GCC centres

● Ethical & Cultural Considerations in GCC ECMO

Withdrawal of ECMO Support

Withdrawal of life-sustaining treatment in GCC follows Islamic bioethical principles — requires careful, respectful communication with families.
  • Islamic bioethics: preservation of life is paramount; extraordinary measures not obligatory if futile
  • Fatwa (religious ruling) may be sought by family in difficult decisions
  • Family consensus preferred — extended family may be involved
  • Hospital ethics committee involvement for complex cases
  • Palliative care team integration — increasing across GCC
  • Documentation of decision-making process essential

Religious & Family Support in ECMO ICU

  • Prayer: Adhan (call to prayer) and Quranic recitation — important comfort measure for Muslim patients
  • Qibla (direction of Mecca) orientation for bed placement where feasible
  • Family visitation: infection control requires limiting visitors, but flexibility for dying patients
  • Female patients: maintain modesty during ECMO care procedures
  • Ramadan: fasting exempted for critically ill patients — but family may wish to participate in care during Iftar/Suhoor times
  • Hospital chaplaincy/Imam service available in all major GCC hospitals

● Paediatric ECMO in GCC

Indications

  • Congenital heart disease post-operative repair — most common indication in GCC tertiary paediatric cardiac centres
  • Failure to wean from cardiopulmonary bypass
  • Post-operative low cardiac output syndrome
  • Neonatal respiratory failure (CDH, MAS, PPHN)
  • Paediatric myocarditis
  • Paediatric ARDS (including MERS-CoV and COVID-19)

Paediatric Nursing Considerations

  • Weight-based flow calculations (target: 100–150 mL/kg/min neonates)
  • Blood prime circuit for neonates/small children — reduces haemodilution
  • Temperature regulation more critical — neonates hypothermia risk
  • Developmental care: touch, voice, gentle stimulation within circuit limits
  • Family presence: parents at bedside — ECMO education essential
  • Play therapy and psychological support for older children on ECMO

▲ ECMO Circuit Assessment Checklist

Next check due: —

■ Circuit Checks

Pump speed (RPM) — within prescribed range
Flow (L/min) — within prescribed range
Oxygenator membrane colour — post-membrane blood bright red
No visible clots or fibrin strands in circuit
No air visible in circuit tubing
No tubing kinks — full circuit traced
Heat exchanger water level adequate, no leaks
Sweep gas — flow rate and FiO₂ correct, gas flowing
All connections secure — no leaks

■ Patient Checks

SpO₂ — within target range (VV: 88–95%)
MAP — within target (65–80 mmHg)
Heart rate — within acceptable range
Cannula exit sites — clean, dry, intact, no bleeding/haematoma
Anticoagulation — UFH/ACT due? Last result documented
Urine output >0.5 mL/kg/hr — adequate
Neurological check — GCS/pupils documented

⚠ Flagged Abnormal Findings — Action Required

    ⚠ ECMO EMERGENCY ESCALATION PROTOCOL

    1. CALL ECMO SPECIALIST IMMEDIATELY — state patient name, location, ECMO mode, nature of emergency
    2. Call ICU Consultant — simultaneous notification
    3. Air in circuit: STOP pump, clamp all lines, do NOT restart until specialist clears air
    4. Oxygenator failure: Maximise ventilator support, prepare emergency circuit change
    5. Accidental decannulation: Apply direct pressure, call vascular/surgery, massive haemorrhage protocol
    6. Circuit clot: Do NOT increase flow — notify specialist, prepare circuit change
    7. Power failure: Activate hand crank immediately — maintain minimum 1 L/min flow
    8. Document: Time of event, findings, actions, personnel notified
    9. Brief whole team — clear roles: one nurse on circuit, one on patient, one on documentation

    Assessment Log

    • No assessments logged yet.